. 2022 Dec 13;12:21494. doi: 10.1038/s41598-022-26017-0

Table 3.

Follow up clinical manifestation.

Patient ID	Duration of follow up (years)	Eye	BCVA (logMAR)		VF at last follow up*	Intraocular pressure (mmHg)		IOL	Other ophthalmological condition	Treatment/intervention during follow up period
Patient ID	Duration of follow up (years)	Eye	Onset	Last visit	VF at last follow up*	Onset	Last visit	IOL	Other ophthalmological condition	Treatment/intervention during follow up period
P1	10.7	OD	0.18	0.20	decreased	13	12	No	None
P1	10.7	OS	0.18	0.20	decreased	14.5	10	No	None
P2	9.2	OD	0.60	1.9	stable	14	9	Yes	Cataract NS + 1	Cataract removal & IOL
P2	9.2	OS	0.48	0.48	improved	14	12	Yes	Cataract NS + 1	Cataract removal & IOL
P3	0.08	OD	0.78	0.60	NE	16.5	16	No	Cataract mild NS
P3	0.08	OS	0.60	0.78	NE	17	15	No	Cataract mild NS
P4	22	OD	0.60	2.7	NE	17	15	Yes	Cataract mild NS	Cataract removal & IOL
P4	22	OS	0.48	3	NE	17	15	Yes	Cataract mild NS	Cataract removal & IOL
P5	11.7	OD	0.20	0.20	decreased	14	15	Yes	Cataract mild NS + PSC	Cataract removal & IOL
P5	11.7	OS	0.20	0.20	decreased	15	15	Yes	Cataract mild NS + PSC	Cataract removal & IOL
P6	15.7	OD	2.3	2.3	NE	15	15	Yes	Absolute glaucoma	Trabeculectomy
P6	15.7	OS	2.7	2.7	NE	10	19	Yes	Absolute glaucoma	Trabeculectomy
P7	6.3	OD	0.60	0.50	NE	NE	17	No	None
P7	6.3	OS	0.60	0.90	NE	NE	17	No	None

*In comparison to baseline clinical data.

BCVA, best corrected visual acuity; IOL, intraocular lens; logMAR, logarithm of the minimum angle of resolution; NE, not evaluated; NS, nuclear sclerotic (cataract); OD, oculi dextra; OS, oculi sinistra; PSC, posterior subcapsular cataract; VF, visual field.